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The maintenance of viable and functional islets is critical in successful pancreatic islet transplantation from cadaveric sources.
During the isolation procedure, islets are exposed to a number of insults including ischemia, oxidative stress and cytokine
injury that cause a reduction in the recovered viable islet mass. A novel approach was designed in which streptozotocin
(STZ)-damaged rat pancreatic islets (rPIs) were indirectly cocultured with rat bone marrow-derived mesenchymal stem cells
(rBM-MSCs) to maintain survival of the cultured rPIs. The results indicated that islets cocultured with rBM-MSCs secreted an
increased level of insulin after 14 days, whereas non-cocultured islets gradually deteriorated and cell death occurred. The
cocultivation of rBM-MSCs with islets and STZ-damaged islets showed the expression of IL6 and transforming growth
factor-b1 in the culture medium, besides the expression of the antiapoptotic genes (Mapkapk2, Tnip1 and Bcl3), implying the
cytoprotective, anti-inﬂammatory and antiapoptotic effects of rBM-SCs through paracrine actions.
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Pancreatic islet transplantation has the potential to replace
insulin-secreting b-cell mass and restore insulin-regulated
glucose homeostasis in patients with type 1 diabetes mellitus.
Despite the recent developments in the isolation of pancreatic
islets, only a part of the total islet can be successfully
recovered by the present protocols.
1 Even more, a function-
ality loss was detected in more than a half of these isolated
islets.
2 To be successful in the b-cell islet transplantation,
many problems associated with maintenance of viable,
functional islets isolated from cadaveric sources should be
solved. The isolation of islets is performed through mechani-
cally enhanced enzymatic digestion of the pancreas, which
dissociates the islets from the surrounding acinar and ductal
tissues.Duringthis process,islets areexposedtoanumberof
insults including ischemia, oxidative stress and cytokine injury
that may result in cellular damage and functional impairment,
which ultimately leads to a reduction in the viable islet mass
recovered.
3 Therefore, different strategies were investigated
for improving the results of experimental and clinical
islet isolation.
3–16 Among these attempts, the antiapoptotic
and protective effects of some compounds, functioning
as cytoprotectives, such as nicotinamide,
3 lisofylline,
5
exendine-4,
6 interleukin (IL)4,
10 prolactin
12 and proteinkinase
Cepsilon,
13wereexaminedonisletcellsinvivoand/orinvitro.
In other studies, many approaches of cellular application
were used.
4,7,9,11,14–16
The ﬁrst study in promoting the survival and function of islet
b-cells in tissue culture was realized by Rabinovitch et al.
4
They cocultured (direct) islet cells from newborn rat pan-
creases with ﬁbroblasts from a mouse embryonic cell line
(3T3-L2). They concluded that ﬁbroblastic cells produce a
macromolecular factor(s) capable of enhancing the survival of
functional islet b-cells in tissue culture.
4 Similar approaches
were tested using pancreatic ductal cells (DECs),
16 MNNK-1
cells,
7 bone marrow (BM) mononuclear cells
9 and rat
pancreatic extracts (RPEs)
15 on the viability and function of
pancreatic islets. In all these studies, the islets were directly
cocultured with the cell components. As a result, cells,
extracts and even stem cells could have a promising effect
on the protection of islets from damage during culture.
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www.nature.com/cddisHere, we designed a novel approach to maintain the
viability and functionality of the cultured rat pancreatic islets
(rPIs) by indirect coculturing of streptozotocin (STZ) injured
and untreated rPIs with rat bone marrow-derived mesench-
ymal stem cells (rBM-MSCs). The rBM-MSCs in the coculture
islets maintained their viability and functionality as shown
by the increased level of insulin secretion in comparison
with monocultures. A gradual destruction was observed in
monocultured islets, especially in those injured with STZ.
Ultimately, cell death occurred after 14 days of incubation.
Results
Light microscopy of cultured islets. Examinations of
cultured islets under an inverted microscope showed that
they displayed a regular cellular structure (Figure 1a). There
were no disintegrated islets.
Staining of islets with dithizone. After cultivation, some
islets were immediately separated and treated with dithizone
(DTZ). All the islets stained with DTZ became crimson red.
No other cell types were observed with the islets, indicating
that only islets were present in the preparation (Figure 1b).
Cell culture of rBM-MSC. MSCs attached to the culture
ﬂasks sparsely and a majority of the cells displayed a
ﬁbroblast-like, spindle-shaped morphology during the early
days of incubation. These cells began to proliferate after 3–4
days, and gradually grew to form small colonies that were
termed colony-forming units (Figure 1c). By days 6–8, the
number of cellular colonies with different sizes had
increased. As growth continued, colonies gradually
expanded in size and the adjacent ones interconnected
with each other. These primary cells reached monolayer
conﬂuence after plating for 12–15 days in their ﬁrst
passages. In later passages, most of these MSCs exhibited
large, ﬂattened or ﬁbroblast-like morphology (Figure 1d). No
changes in morphology or growth pattern were observed
throughout 25 passages.
Flow cytometry: identiﬁcation of rBM-MSCs. Both
previous and present data indicated that rBM-MSCs
expressed CD29 and CD90, but not CD45 (data not
shown).
17 rBM-MSCs maintained their phenotype
throughout passages. Therefore, there was no evidence of
hematopoietic precursors in the cultures. In contrast, the
expression of other surface antigens agreed with the
previous reports regarding murine MSCs, and indicated
that the cells used in this study had the characteristics of
MSCs reported in other studies.
17–19
Immunocytochemistry: identiﬁcation of rBM-MSCs.
Immunohistochemical studies were performed to
characterize the progeny of the rBM-MSCs by using a large
panel of antibodies speciﬁc to known antigens associated
with different phenotypes. The immunocytochemical staining
results are shown in Supplementary Figures 1 and 2, and
Supplementary Table 1.
The antigenic phenotype of MSCs is not unique and no
single marker has been found to be speciﬁc for MSCs.
However, in the past, certain antigens such as surface and
cytoplasmic proteins have been used in attempts to charac-
terize MSCs. Expression of some of these antigens was also
examined for the rBM-MCSs in this study. Under standard
Figure1 MorphologyofPIsandrBM-MSCs.(a)Free-ﬂoatingratislets(arrows).(b)RatisletsstainedwithDTZforspeciﬁcity.(c)Duringtheonsetofgrowth(P0-13thday),
isolatedcellsfromthebonemarrowformedsingle-cell-derivedcolonies(arrows).Inlaterpassages,mostoftheseMSCsexhibitedlarge,ﬂattenedorﬁbroblast-likemorphology
(P1-12th day) (d) (Original magniﬁcation: a, c  40; b, d  200)
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Cell Death and Diseaseculture conditions, a-smooth muscle actin (Acta2), actin-b
(Actb), osteopontin (secreted phosphoprotein 1, Spp1), glial
ﬁbrillary acidic protein (GFAP), FBJ osteosarcoma oncogene
(Fos), CD45, osteocalcin, osteonectin (secreted acidic
cysteine-rich glycoprotein, Sparc), myosine IIa (Supplemen-
taryFigure1),b-tubulin(Tubb3),nestin(Nes),ﬁbronectin(FN)
and BMP2 (Supplementary Figure 2), vimentin (Vim), desmin
(Des), bone morphogenetic protein 4 (BMP4), myogenin
(Myog), type I and II collagen, and CD105 (data not shown)
were expressed. rBM-MSCs of this study did not express
some surface markers including CD31 (endothelial) (Supple-
mentary Figure 2C), CD34 (data not shown), CD45 (hema-
topoietic markers) (Supplementary Figure 1F) and CD71
(Supplementary Figure 2D).
Gene expression proﬁles of rBM-MSCs. Supplementary
Table 2 summarizes the results of the RT-PCR analysis of
rBM-MSCs. The expressions of some of the key transcripts
for embryonic stem cell genes (Pou5f1, Zfp42) indicated the
self-renewal capacity of rBM-MSCs. The cells were also
found to be positive for Actb, glyceraldehyde 3-phosphate
dehydrogenase (Gapdh), Vim, Acta2, Des, Myog, Nes, Gfap,
Eno2, Tubb3, Sparc, Bmp4 and Spp1, showing that their
expression is the indication of the differentiation to other
tissues (Figure 2).
The expression of myogenic (Des, Myog, MyosinIIa,
Acta2), neurogenic (enolase-g (Eno2), MAP2a,b, Fos, Nes,
Gfap, Tubb3) and osteogenic (Sparc, Osteocalcin, Spp1,
BMP2, BMP4, type I Collagen) markers by BM-MSCs without
induction is the explanation for the possible reason of the fact
thatthesecellscanreadilydifferentiate intofunctionalmultiple
lineages both in vitro and in vivo.
It was also shown that rBM-MSCs expressed myogenic,
neurogenic and osteogenic genes under basal conditions
designating the diverse immunophenotypic characteristics of
MSCs that might explain the reason why these cells could
easily differentiate into cells of bone, cartilage, muscle and
neural tissues. Consistently, the expression of precursor
markers of mesoderm and ectoderm by MSCs indicates that
they could differentiate into cells of three germ layers under
permissive in vitro conditions.
MSCs were investigated for the presence of molecules
involved in immunomodulation or suppression. Mitogen-
activated protein kinase-activated protein kinase 2 (MAP-
KAPK2) is related to kinases that mediate a wide range of
biological functions in response to mitogens and stress
stimuli. Tnip1 (TNFAIP3 (tumor necrosis factor, a-induced
protein 3)-interacting protein 1), which is previously known as
A20, is another antiapoptotic gene (stress gene) like
Mapkapk2 expressed by both cell lines (Supplementary Table
2, Figure 2). In addition, rBM-MSCs expressed Bcl3 (B-cell
leukemia) (antiapoptotic gene) and interleukin 6 receptor-a
(IL6ra) but failed to express IL10 and interferon-g (Ifng)
(Supplementary Table 2, Figure 2). IL6ra, also known as
CD126, is a type I cytokine receptor. Interleukin 6 (IL6)i sa
potent pleiotropic cytokine that regulates cell growth and
differentiation and has an important role in immune response.
Differentiation potential of rBM-MSCs
Adipogenic differentiation. rBM-MSCs at passage 3 (P3)
were used in the adipogenic differentiation experiments, in
which 80–90% sub-conﬂuence was found to be optimal for
cell differentiation that lasted for 2–3 weeks. At the beginning
of the third week, lipid droplets enlarged and invaded the
entire cytoplasm of the adipocyte-differentiated rBM-MSCs
(Supplementary Figure 3).
Osteogenic differentiation. Histo- and/or immunohisto-
chemical techniques for the detection of bone-speciﬁc
markers were applied to cells grown in osteogenic
differentiation medium and in control medium to assess the
osteogenic differentiation of rBM-MSCs. Proliferation and
differentiation of both cultures were compared using phase
contrast microscopy. In both control and osteogenic cultures,
cells proliferated and reached almost complete conﬂuency
after 8–10 days of incubation. Later, the cellular aggregates
were observed in osteogenic differentiation culture plates
and gradually increased until the completion of the
experiment. These aggregates were characterized by the
presence of amorphous material deposits (Supplementary
Figure 4A). The staining of these nodular aggregates in
osteogenic cultures by Alizarin red S showed that the
amorphous deposits observed at the microscope were
actually calcium deposits. Alizarin red positive nodular
aggregates were already present at day 15 (Supplementary
Figure 4B) and control cultures showed only minimal
background staining (Supplementary Figure 4D). Cells that
were incubated for 15 days were also strongly stained
positive for BMP4 (Supplementary Figure 4C), osteopontin
(Supplementary Figure 4C), osteocalcin (data not shown)
and extracellular located matrix proteins BMP2 (data not
shown).
Figure 2 Agarose gel electrophoresis of RT-PCR products. Representative
panel of RT-PCR analysis of rBM-MSCs. Internal control: glyceraldehyde
3-phosphate dehydrogenase (Gapdh). Negative control: PCR mix without template
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Cell Death and DiseaseAntiapoptosis ability of rBM-MSCs on STZ-induced
pancreatic islets. After coculture experiments, quantitative
analysis of apoptosis was conducted by FACS (AnnexinV/PI)
and microscopic evaluations on the islets stained with
ﬂuorescein diacetate (FDA)/propidium iodide (PI).
For determination of cell viability in normal and STZ-
induced pancreatic islets cocultured with rBM-MSCs,
FDA/PI staining was performed. In Figure 3, the images
of rPIs cultured under different conditions are given. Dead
cells stained red and viable cells stained green.
The percentage viability of islet cells was calculated as
described in the Materials and Methods section. As shown in
Figure 4c, STZ induced a signiﬁcant decrease in the
viability rates of islets compared with untreated islets
(10%±2.8, 60%±2.81, respectively; Po0.001). In contrast,
coculture with rBM-MSCs induced a signiﬁcant increase
in viability rates in STZ-induced islets (72.5%±4.01;
Po0.001).
Figure 3 Cell viability. For determination of cell viability in normal (a, b) and STZ-induced pancreatic islets cocultured with rBM-MSCs (c, d), PI/FDA staining was
performed. The small brightspots in theﬂuorescentmicrographscorrespond to theintense red staining of PI-positive(dead) cells.The diffuselystained regions correspond to
the FDA-stained (live) cells (Scale bars¼50mm)
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Cell Death and DiseaseCell apoptosis was measured by Annexin V-FITC, which
binds to phosphatidylserine residues that are redistributed
from the inner to the outer leaﬂet of the cell membrane as
an early event in apoptosis. After loss of membrane integrity,
PI can enter the cell and intercalate into DNA.
20 Figure 4a and
b shows the percentages of Annexin V-PI-stained cells of
islets. The average percentages of Annexin Vþ/PIþ (late
apoptotic cells) were highest in STZ-induced islets
(67.34%±1.8) and the percentage in islets cocultured with
rBM-MSCs was the lowest (19.3%±1.4). Moreover,
there was a statistical signiﬁcance between STZ-induced
islets and STZ-induced islets cocultured with rBM-MSCs
(52.26%±1.04) (Po0.01) as well as the rate of Annexin V /
PI (viablecells),AnnexinVþ/PI (earlyapoptoticcells)and
Annexin V /PIþ (necrotic cells) (data not shown). Therefore,
this suggested that islets cocultured with rBM-MSCs had a
superior tolerance to STZ-induced cytotoxicity.
Insulin content. The content of total cellular insulin in
experimental groups was evaluated and it was found that
STZ-induced islets showed a signiﬁcant decrease in cellular
insulin content in comparison to the untreated islets when
induced with L-DMEM and H-DMEM (3.38±0.79ng/mg
protein and 9.72±0.68ng/mg protein in L-DMEM, and
5.25±1.43ng/mg protein and 10.51±0.91ng/mg protein in
H-DMEM, with respect to STZ-induced islets and untreated
islets; Po0.01) (Figure 5). The proportion of insulin release
to insulin content in STZ-induced islets cocultured with rBM-
MSCs was estimated to be approximately 9.77±0.66ng/mg
protein in L-DMEM and 10.53±0.64ng/mg protein in
H-DMEM (Figure 5).
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Figure 4 Detection of apoptosis. (a) Apoptosis was quantiﬁed by FACS analysis
after staining with Annexin V and PI at the end of the experiment (day 14) (islets were
incubatedwithtrypsintoobtaindispersedcells).ViablecellswereAnnexinV /PI (III),
early apoptotic cells were Annexin Vþ/PI  (IV), late apoptotic cells were Annexin
Vþ/PIþ (II) and necrotic cells were Annexin V /PIþ (I). Representative examples
are shown in b.( c) We also performed PI/FDA staining for determination of cell viability
in normal and STZ-induced pancreatic islets cocultured with rBM-MSCs and calculated
as described in Methods. STZ induced a signiﬁcant decrease in the viability rates in
islets compared with untreated islets (10%±2.8, 60%±2.81, respectively). Coculture
with rBM-MSCs induced a signiﬁcant increase in viability rates in STZ-induced islets
(72.5%±4.01; Po0.001). (mean±S.D., n¼3e a c h ,* * Po0.01, ***Po0.001)
Figure 5 Insulin release in response to glucose stimulation of islets in different
groups. On day 14, normal islets, islets cocultured with rBM-MCSs, STZ-induced
islets and STZ-induced islets cocultured with rBM-MSCs secreted insulin into the
medium and the insulin was increased under glucose challenge. However, the
insulin secretion level of STZ-induced islets was decreased more signiﬁcantly than
in other groups, similar to under H-DMEM conditions. Interestingly, injured islets
cocultured with rBM-MSCs released insulin into culture medium under glucose
stimulation, similar to normal islets. Data represent the mean±S.E. of values of
three independent measurements. Data were analyzed for signiﬁcant change by
using two-way ANOVA and paired t-test (*Po0.05; **Po0.01)
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Cell Death and DiseaseCytokine secretion. Transforming growth factor-b1
(TGF-b1), IL4 and IL6 were found to be secreted by rBM-
MSCs independent of the cocultured islets. The analysis of
three cytokines (TGF-b1, IL4 and IL6) in all three cell culture
supernatants showed that all of the monocultures have
detectable concentrations of these cytokines. Only the
concentrations of IL4 were not altered in cocultures (data
not shown). The coculturing of rBM-MSCs with islets and
STZ islets led to an increase in secretion of IL6 and TGF-b1
in comparison to monocultures of rBM-MSCs, islets and STZ
islets (Figure 6).
Discussion
Therapeutic effects of MSCs are believed to occur not only by
direct differentiation into injured tissue but also by production
of paracrine and autocrine factors. MSCs at the injured tissue
environments can promote the secretion of a variety of
cytokines and growth factors that have both paracrine and
autocrine activities.
21,22 On this line, several studies have
been performed. For instance, in probing the mechanism of
treating effects of MSCs transplanted into the infracted heart,
several researchers noticed that MSCs undergoing hypoxia
environments stimulated the infracted heart local microenvir-
onment to secrete more amounts of cardioprotective vital
growth factors to inhibit cardiomyocyte apoptosis compared
with MSCs in vitro cultured under normoxia.
23 Gatto et al.
16
reported that DECs are putative stem cells for islets, which
might secrete speciﬁc factors supporting islet growth and
function.Therefore,theeffectsofdirectcoculturingwithDECs
on the viability of fresh and cryopreserved human pancreatic
islets were studied. The results indicated that the coculture
process representsa valuabletool to improve the survival and
functional activity of islets.
16 Miki et al.
7 showed that coculture
of the mouse, rat and pig islets with MNNK-1 cells that served
as a feeder cell in the coculture maintained their viability and
insulin secretion with glucose responsiveness.
7 Luo et al.
9
examined the reparative effects of allogeneic BM mono-
nuclear cells that were placed in culture with isolated human
islets. Coculture with BM showed the ability of damage repair
by human islets resulting in functional insulin release from
islets in the long term. They suggested that BM increases
survival of islets and function with the eventual formation of
pancreatic endocrine tissue capable of sustaining b-cell
function.
9 Chao et al.
11 designed an approach to maintain
the cultured rat pancreatic islet-like cell cluster (ICC) survival
and function, when cocultured with human umbilical cord
mesenchymal stem cells (HUMSCs). Their ﬁndings suggest
that coculture with HUMSCs may have a signiﬁcant potential
to protect ICCs from damage.
11 Similarly, Xu et al.
15 studied
the impact of RPE on cytokine secretion by MSCs and
examinedtheinﬂuenceofadministrationofconditionedmedia
of MSCs treated with RPE on blood glucose levels in diabetic
rats. Their report indicated that RPE enhanced the secretion
of cytokines by MSCs. MSCs in the pancreatic microenviron-
ment might exert indirect salutary effects through paracrine
mediators on injured pancreatic cells in an STZ-induced
diabetic animal model. The secreted factors may exert their
therapeutic beneﬁts by preventing apoptosis of pancreatic
b-cells.
15 More recently, Solari et al.
14 examined the
immunoregulatory effect of autologous MSCs on sub-optimal
numbers of islets co-transplanted into an omental pouch to
enhance insulin secretion and sustained normoglycemia in a
model of STZ-induced diabetic rats. They have shown that
allogeneic islets with autologous MSCs induced insulin
secretion and promoted long-term islet allograft survival.
14
In this study, we used a novel approach to maintain viability
andfunctionalityoftheculturedrPIs.Inthisapproach,cultures
were separated by a membrane preventing any direct
interaction between islets and rBM-MSCs. In routine cultures,
STZ induction reduced the viability and functional activity of
rPIs compared with non-inductive islets (fresh tissue).
However, it was found that rBM-MSCs in coculture had the
ability to maintain islet viability and functionality, proven by
prolonged insulin secretion by islets for 14 days. Unlike
protected islets, a gradual destruction was observed in
unprotected islets and a signiﬁcant loss of function was
observed in islets injured by STZ ultimately leading to cell
death after 14 days of incubation.
It has also been shown that in vitro expanded and puriﬁed
rat MSCs spontaneously secrete TGF-b1, hepatocyte growth
factor and IL6, but not IFNG, IL4, IL5 or IL10.
24,25 It was
Figure 6 Cytokine secretion evaluated by ELISA. The expressions of TGF-b1
andIL-6werequantiﬁedinvariousmonoculturesincludingislets,STZ-inducedislets
and rBM-MSCs and cocultures including isletsþrBM-MSCs and STZ-induced
isletsþrBM-MSCs.Datarepresentthemean±S.E.ofvaluesofthreeindependent
measurements. Data were analyzed for signiﬁcant change by using two-way
ANOVA and paired t-test (*Po0.05; **Po0.01)
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Cell Death and Diseaseconsidered rather that MSCs promote tissue repair by
secreting soluble factors that modulate inﬂammation and
angiogenesis.
26 In this study, the cocultivation of rBM-MSCs
with islets and STZ islets led to an increase in IL6 and TGF-b1
into the culture supernatant in comparison with monocultures
of rBM-MSCs, islets and STZ islets. Secretion of these
cytokinesbyMSCscouldhavearoleintheiranti-inﬂammatory
or antiapoptotic function.
Oh et al.
27 showed that human MSCs secreted small
amounts of IL6 while secreting large amounts of TGF-b1 into
the culture medium.
27 Moreover, increased IL6 secretion
was shown when hMSCs were cocultured with chemically
damaged human corneal epithelial cells (hCECs). This is in
agreement with the data reporting upregulation of IL6 in
stimulated MSCs.
28,29 In a recent study, it has been
suggested that suppressive effects of MSCs can be through
IL6 by inhibiting lymphocyte apoptosis.
30 Their ﬁndings
pointed out that MSCs inhibit apoptosis of lymphocytes, and
that soluble factors, mainly IL6 secreted by MSCs after direct
interaction with lymphocytes, have an important role in their
antiapoptotic function. In another report, IL6 mediated
antiapoptotic effects and drug resistance mechanisms
through both STAT3 and bcl-xL pathways in prostate cancer
cells were revealed.
31 In this study, IL6 and its speciﬁc
receptor (IL6RA) were expressed by rBM-MSCs, and these
data might show the antiapoptotic effect of MSCs. In addition,
it has been shown that MSCs suppress various immune
functions through a release of immunosuppressive soluble
factor, TGF-b1.
32
SPP1 is a highly hydrophilic and negatively charged sialo-
protein of approximately 298 amino acids that contains a
Gly-Arg-Gly-Asp-Sermotif.SSP1existsbothintra-andextracel-
lularly. It has been shown that Ssp1 is expressed in the
pancreatic islets of the rat and that its pancreatic levels are
acutelyupregulatedinresponsetoSTZ-induceddiabetes.Itwas
also shown that SSP1 protects the islets from STZ-induced no
production.
33 SSP1 also prevents IL-1b -induced rat islet
dysfunction.
8 In this study, it was shown that rBM-MSCs
expressed SSP1 at the levels of gene and protein without
stimulation. Therefore, it was considered that SSP1 could be
secretedbyrBM-MSCsintococulturemediumandcouldprotect
islets from destruction. Moreover, it has been observed that
FN treatment signiﬁcantly inhibited lipopolysaccharide (LPS)-
induced apoptotic activities in FN-treated MSCs-derived
hepatocyte-like cells and improved the survival rates of LPS-
induced SCID mice.
34 This study showed that FN was
expressed by rBM-MSCs at both the gene and protein levels.
Genes with known antiapoptotic functions, and those
expressed under stress include Mapkapk2, Tnip1 and Bcl3.
The expressions of these genes by stem cells were examined
in this study. MAPKAPK2 is a direct substrate of p38 MAP
kinase in response to cellular stress such as mechanical
stress, heat shock, osmotic stress, UV irradiation, bacterial
LPS, several inﬂammatory cytokines and growth factors.
35
TNIP1 was originally described as an antiapoptotic TNF-a-
induced gene in endothelial cells.
36 BCL3, in complex with
p52, can promote transcription of the genes encoding the cell
cycle regulator cyclin D1 and the antiapoptotic BCL2
protein.
37 The presented data showed the expression of
all three genes in rBM-MSCs. Expression of these genes by
rBM-MSCs might imply the role of rBM-SCs and highlight the
antiapoptotic inﬂuence mechanisms that could have a
protective role on pancreatic islet cells.
Overall, the underlying mechanisms modulating pancreatic
islet viability might be attributed to the paracrine mediators
IL6, TGF-b1, SSP1 and FN secreted by MSCs. Coculturing
with rBM-MSCs might have a signiﬁcant potential to protect
STZ-induced injured pancreatic islets through paracrine
actions such as cytoprotective, anti-inﬂammatory and anti-
apoptotic effects. In this study, an indirect coculture approach
was used for the ﬁrst time to protect and improve islet viability
and its functionality, although several other studies, in which
islets were directly cocultured with cellular extracts or with
various cell types (e.g., ﬁbroblasts, pancreatic ductal cells,
MNNK-1 cells BM-mononuclear cells) to reach the same
target, bring about the requirement for separation
afterwards.
4,7,9,11,14–16 The uniqueness of our approach is
the elimination of mixing the different cell populations or
contaminating cell extracts by placing a separator (insert)
between the islets and the cells/cell extracts. Therefore, the
approach used in this study would be very important in
allogeneic islet transplantations and clinical practices.
Materials and Methods
Animals. Wistar male rats (8–10 weeks old) were obtained from the
Experimental Animal Center of Kocaeli University (Kocaeli, Turkey). Animal
housing and experiments were approved by the local animal care committee
according to the institutional guidelines and national animal welfare. They were
housed under standard conditions for a week before use.
Isolation of islets. Islets were isolated as described
38 and cultured in RPMI
1640 (Invitrogen/GIBCO, Grand Island, NY, USA) with glucose 2g/l supplemented
with 10% fetal bovine serum (FBS; Invitrogen/GIBCO), 100IU/ml penicillin-100mg/ml
streptomycin (Invitrogen/GIBCO) and glutamine (2mmol/l; Invitrogen/GIBCO) at
371C in a humidiﬁed air atmosphere containing 5% CO2.
Islets were then tested for their speciﬁcity by DTZ staining. DTZ staining was
carried out by adding 10ml DTZ stock solution to islets suspended in 1ml Krebs-
Ringer bicarbonate buffer (pH 7.4) with HEPES (10mM) (KRBH) and incubated at
371C for 10–15min. The stained islets appeared as bright red under the inverted
microscope(CKX41,Olympus,Tokyo,Japan).Non-islettissueremainedunstained.
Isolation and culturing of rBM-MSCs. To establish the MSC culture, the
animals were anesthetized with Ketalar (Pﬁzer, Kırklareli, Turkey) and killed by
cervical dislocation method. Under sterile conditions, both femur and tibiae from
each rat were excised. Muscle and the entire connective tissue were detached. The
ends of the bones were removed and a 21-gauge needle, inserted into the shaft of
theBM,wasextrudedbyﬂushingwithRPMI1640supplementedwith10%FBSand
100IU/ml penicillin-100mg/ml streptomycin that was also used as the growth
medium. Marrow plug suspension was dispersed by pipetting, successively ﬁltered
through 70mm mesh nylon ﬁlter (BD Biosciences, Bedford, MA, USA), and
centrifuged at 200g for 10min. Supernatant containing thrombocytes and
erythrocytes was discarded, and the cell pellet was resuspended in the medium.
Thecellsfromoneratwereseededontotwo25cm
2plastictissuecultureﬂasks(BD
Biosciences)andincubatedat 371C in a humidiﬁedatmosphere containing5% CO2
for 3 days. The mesenchymal stem cells were isolated on the basis of their ability to
adhere to the culture plates. On the third day, red blood cells and other non-
adherent cells were removed and fresh medium was added to allow further growth.
The adherent cells grown to 70% conﬂuency were deﬁned as passage zero (P0)
cells. The P0 MSCs were washedwith Ca
2þ-Mg
2þ free phosphate-buffered saline
(PBS) (Invitrogen/GIBCO) and detached by incubating with 0.25% trypsin-EDTA
solution (Invitrogen/GIBCO) for 5–10min at 371C. Complete medium was added to
inactivatethetrypsin.Thecellswerecentrifugedat200gfor10min,resuspendedin
1ml complete medium and counted manually in duplicate using the Thoma
chamber. Then the cells were plated as P1 in 75cm
2 ﬂasks (BD Biosciences) at
densities of 1 10
6 cell/ﬂask. Complete medium was replaced once every 3 days
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grown to a conﬂuency of 70%.
Phenotype identiﬁcation of rBM-MSCs
Flow cytometry. To conﬁrm that rBM-MSCs maintain their phenotypic
characteristics after growth in culture, undifferentiated MSCs were subjected to
ﬂow cytometry analysis. Flow cytometry was performed on an FACS Calibur (BD
Immunocytometry Systems, San Jose, CA, USA) and the data were analyzed with
the Cell Quest software (BD Immunocytometry Systems). Immunophenotyping of
rBM-MSCs was performed with antibodies against rat antigens CD29 (Integrin-b1
chain; Ha2/5;FITC), CD45 and CD90 (Thy-1/Thy-1.1-FITC), as well as their isotype
controls (IgG2aK; FITC) (BD Biosciences, San Diego, CA, USA).
Immunohistochemistry. The immunohistochemistry studies on the P0,P 1,P 3,
P4,P 7,P 9andP10cellswereperformedaspreviouslydescribedbyusandusedprimary
antibodies were listed in Supplementary Table 1.
17 The mounted cells were examined
under a light/ﬂuorescence microscope (Leica DMI 4000B, Wetzlar, Germany).
Reverse transcription-polymerase chain reaction. Total RNA was
isolated from rat islets and P3 cell cultures (rBM-MSCs) by the High Pure RNA
IsolationKit(Roche, Mannheim, Germany)andcDNAwassynthesizedbyusingthe
Transcriptor High Fidelity cDNA Synthesis Kit (Roche). The PCR mix consisted of
1  PCR buffer, 0.2mM dNTPs, 0.5mM of each primer (Supplementary Table 2),
1.25mM MgCl2 and 1.5U of Taq DNA polymerase. The PCR products were
analyzed by agarose gel (2%) electrophoresis. Sequences and annealing
temperatures of each primer pair are listed on Supplementary Table 2. The
studied genes were selected: (i) to show that MSCs have diverse
immunophenotypic characteristics and could be characterized by studying the
expression of Spp1, Sparc, Bmp4, Gfap, tubulin beta 3 (Tubb3), Eno2, smooth
muscle a-actin (Acta2), actin-b (Actb), Myog, Des, Nes, Fos and Vim genes; (ii) to
relate the antiapoptotic and anti-inﬂammatory effects of MSCs cocultured with STZ-
injured islets following the expression of apoptosis-related genes, such as IL6ra,
TNFAIP3 interacting protein 1 (Tnip1), Bcl3, Ifng and IL10. In the study, the
housekeeping gene, Gapdh, was selected as the internal control.
InvitrodifferentiationofrBM-MSCs. Theinvitrostudiesofadipogenicand
osteogenic differentiations were performed according to the methods described
previously by Karaoz et al.
17
Apoptosis induction in pancreatic islets
In vitro STZ treatment to apoptosis induction. STZ was prepared 1min
before use by dissolving in 0.1mol/l sodium citrate (pH 4.5) at 41C a concentration
of 200mmol/l. A volume of 10ml of this solution was added to the islets to obtain
1mmol/l STZ. Islets were then incubated overnight (14h).
39 In the next
experimental set STZ-induced isletsþMSCs group, STZ induction was
performed in the presence of MSCs. Later, STZ-exposed islets were transferred
into the upper section of the wells separated by an insert that was previously
prepared by the addition of MSCs.
rBM-MSCs/rPIs indirect coculture experiments. All cocultures were
conductedintriplicatein12-wellplates(BectonDickinsonLabwareEurope,LePont
De Claix, France) using 0.4-mm pore size, high pore density and polyethylene
terephthalate track-etched cell culture inserts (Becton Dickinson Labware Europe).
rBM-MSCs (1 10
5) were seeded in the lower chamber of the coculture system,
and incubated in RPMI 1640 medium including 10% FBS and 1% antibiotic. Once
culturedMSCsreachedconﬂuence,pancreaticislets(normalandSTZ-induced) (20
per well) were then placed on the upper surface of the membrane of the cell culture
inserts. Cocultured cells and islets were maintained for 14 days in RPMI 1640 at
371C and 5% CO2 in a humidiﬁed atmosphere with the medium being changed
every 2 days. Control MSCs without pancreatic islets were prepared in the same
conditions as cocultured rBM-MSCs.
Apoptosis detection in pancreatic islets with/without coculture
Apoptosis detection by FDA-PI viability staining. Islet preparations were
assessed for islet cell viability using cell membrane exclusion dyes.Viability of islets
was assessed using ﬂuorescein diacetate (FDA) (Sigma-Aldrich, St. Louis, MO,
USA) and PI (Sigma-Aldrich) staining.
3 Brieﬂy, islets in the inserts were transferred
in PBS to a Petri dish (35mm). FDA and PI stock solutions were added to the
sample at a ﬁnal concentration of 0.67 and 75mM, respectively. Using a ﬂuorescent
microscope(LeicaDMI4000B),a procedurefor theassessment of intactpancreatic
islet viability was used. After 30s of adding the stain, it was placed in a
Petri dish containing 2.0ml of PBS. The sample was placed on the ﬂuorescent
microscope, visualized and photographed using the ﬁlter FITC for ﬂuorescein
(em B530nm) and rhodamine (em 4600nm). Dead cells were stained red and
viable cells were stained green. The objective of the test was to assess, as
accurately as possible, the percentage of islet cells that were viable. The cells were
assigned to categories as follows: 0: few or no cells were green and the majority
were red (average viability¼non-viable), 1: approximately 75% of the cells were
red (average viability¼25%); 2: approximately 50% of the cells were red (average
viability¼50%); 3: approximately 25% of the cells were red (average
viability¼75%); 4: few or no cells were red (average viability¼100%).
Calculations. Total viable¼0.25 (sum of category 1)þ0.5 (sum of category 2)
þ0.75 (sum of category 3)þ(sum of category 1)
Total number of islets¼(sum of category 1)
Percent viable¼(total viable 100)/total number of islets
Apoptosis detection by ﬂow cytometry. Following coculture experiments,
islets were incubated for 5min with trypsin-EDTA. 0.25% trypsin, 1mM EDTA.4Na
in Hanks’ balanced salt solution without Ca
þ2 and Mg
þ2 at 371C, and islet cells
were gently dispersed.
20 After washing with PBS, apoptotic cell percentage was
detected by ﬂow cytometry with Annexin-V-FITC Apoptosis Detection Kit (BD
Pharmingen).
Measurement of insulin secretion by ELISA. At the end of the 14th
day, inserts including islets were transferred into new 12-well plates and the culture
media were switched to serum-free low glucose (L)-DMEM (5.5mmol/l) containing
0.5%BSA for 2h, washedtwicewith PBS,andthen stimulatedby high glucose(H)-
DMEM (25mmol/l) for 2h. At the end of this second 2h incubation, the culture
media were collected and frozen at  701C until they were assayed for insulin
content. To estimate total cellular insulin levels, the total cell protein content was
testedusingBCAProteinAssayKit(SigmaAldrich).Insulinreleasewasdetectedby
rat insulin enzyme-linked immunosorbent assay (ELISA kit, Linco) according to the
manufacturer’s instructions.
Cytokine quantiﬁcation. Secretions of rat interleukin (IL4, IL6, IL10) and
transforming growth factor (TGF-b1) were determined in supernatants by ELISA
(ELISA kit, Invitrogen, Camarillo, CA, USA) according to the manufacturer’s
recommendations. The minimum detectable dose (MDD) was 2pg/ml for IL4, 7pg/
ml for IL6, 5pg/ml for IL10, and 15.6pg/ml for TGF-b1. All the experiments were
performed in triplicate.
Statisticalanalysis. Allexperimentswererepeatedaminimumofthreetimes.
Data are reported as means±S.D. All statistical analyses were performed using
SPSS 10.0 (SPSS Inc., Chicago, IL, USA). Data were analyzed using one-way
ANOVAandpaired t-test.Differencesbetweentheexperimentalandcontrolgroups
were regarded as statistically signiﬁcant when Po0.05.
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